These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 16702191)

  • 1. PINK1 protein in normal human brain and Parkinson's disease.
    Gandhi S; Muqit MM; Stanyer L; Healy DG; Abou-Sleiman PM; Hargreaves I; Heales S; Ganguly M; Parsons L; Lees AJ; Latchman DS; Holton JL; Wood NW; Revesz T
    Brain; 2006 Jul; 129(Pt 7):1720-31. PubMed ID: 16702191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.
    Villeneuve LM; Purnell PR; Boska MD; Fox HS
    Mol Neurobiol; 2016 Jan; 53(1):171-186. PubMed ID: 25421206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
    Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
    Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
    Dodson MW; Guo M
    Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetics of PINK1].
    Funayama M; Hattori N
    Brain Nerve; 2007 Aug; 59(8):831-8. PubMed ID: 17713119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease.
    Cookson MR; Xiromerisiou G; Singleton A
    Curr Opin Neurol; 2005 Dec; 18(6):706-11. PubMed ID: 16280683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
    Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.
    Orr AL; Rutaganira FU; de Roulet D; Huang EJ; Hertz NT; Shokat KM; Nakamura K
    Neurochem Int; 2017 Oct; 109():106-116. PubMed ID: 28434973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function rodent models for parkin and PINK1.
    Oliveras-Salvá M; Van Rompuy AS; Heeman B; Van den Haute C; Baekelandt V
    J Parkinsons Dis; 2011; 1(3):229-51. PubMed ID: 23939304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
    Eldeeb MA; Ragheb MA
    Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease.
    Blackinton JG; Anvret A; Beilina A; Olson L; Cookson MR; Galter D
    Brain Res; 2007 Dec; 1184():10-6. PubMed ID: 17950257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical properties of the kinase PINK1 as sensor protein for mitochondrial damage signalling.
    Rüb C; Schröder N; Voos W
    Biochem Soc Trans; 2015 Apr; 43(2):287-91. PubMed ID: 25849931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of α-synuclein and PINK1 in Lewy body dementia (Review).
    Minami A; Nakanishi A; Matsuda S; Kitagishi Y; Ogura Y
    Int J Mol Med; 2015 Jan; 35(1):3-9. PubMed ID: 25355138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
    Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.